The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The real world outcomes of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST).
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Speakers' Bureau - Lilly; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre
 
Marcin Zietek
No Relationships to Disclose
 
Bozena Cybulska-Stopa
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis
 
Joanna Streb
No Relationships to Disclose
 
Stanislaw Gluszek
No Relationships to Disclose
 
Michał Jankowski
No Relationships to Disclose
 
Karolina Lopacka-Szatan
No Relationships to Disclose
 
Manuela Las-Jankowska
No Relationships to Disclose
 
Piotr Hudziec
No Relationships to Disclose
 
Anna Klimczak
No Relationships to Disclose
 
Tomasz Olesinski
No Relationships to Disclose
 
Tomasz Switaj
Honoraria - Bristol-Myers Squibb; MSD; Novartis
 
Hanna Kosela-Paterczyk
Honoraria - Bristol-Myers Squibb; MSD; Novartis
 
Elzbieta Bylina
No Relationships to Disclose
 
Czeslaw Osuch
No Relationships to Disclose